Combined Delivery of a Lipopolysaccharide-Binding Peptide and the Heme Oxygenase-1 Gene Using Deoxycholic Acid-Conjugated Polyethylenimine for the Treatment of Acute Lung Injury

Macromolecular Bioscience
Ji Yeon KimMinhyung Lee

Abstract

A ternary complex comprising plasmid DNA, lipopolysaccharide-binding peptide (LBP), and deoxycholic acid-conjugated polyethylenimine (PEI-DA) is prepared for combinational therapy of acute lung injury (ALI). The LBP is designed as an anti-inflammatory peptide based on the lipopolysaccharide (LPS)-binding domain of HMGB-1. In vitro cytokine assays show that LBP reduces levels of proinflammatory cytokines by inhibiting LPS. PEI-DA is synthesized as the gene carrier by conjugation of deoxycholic acid to low-molecular weight polyethylenimine (2 kDa, PEI2k). PEI-DA has higher transfection efficiency than high-molecular weight polyethylenimine (25 kDa, PEI25k). The ternary complex of an HO-1 plasmid (pHO-1), PEI-DA, and LBP is prepared as a combinational system to deliver the therapeutic gene and peptide. The transfection efficiency of the ternary complex is higher than that of the pHO-1/PEI-DA binary complex. The ternary complex also reduces TNF-α secretion in LPS-activated Raw264.7 macrophage cells. Administration of the ternary complex into the lungs of an animal ALI model by intratracheal injection induces HO-1 expression and reduces levels of proinflammatory cytokines more efficiently than the pHO-1/PEI-DA binary complex or LBP ...Continue Reading

References

Jun 22, 1992·The American Journal of Medicine·P B Bitterman
Aug 1, 1991·The Journal of Clinical Investigation·L S SnyderP B Bitterman
Aug 1, 1995·Proceedings of the National Academy of Sciences of the United States of America·O BoussifJ P Behr
Jul 9, 1999·Journal of Biomedical Materials Research·W T GodbeyA G Mikos
Jul 30, 1999·Journal of Controlled Release : Official Journal of the Controlled Release Society·W T GodbeyA G Mikos
May 4, 2000·The New England Journal of Medicine·L B Ware, M A Matthay
May 17, 2001·Bioconjugate Chemistry· Han SoS W Kim
Apr 12, 2002·Journal of Controlled Release : Official Journal of the Controlled Release Society·Cheol-Hee AhnSung Wan Kim
Jun 5, 2002·Annual Review of Biochemistry·Christian R H Raetz, Chris Whitfield
Mar 29, 2003·American Journal of Respiratory and Critical Care Medicine·Michael A MatthayAndrea L Harabin
Feb 18, 2004·Current Medicinal Chemistry·Jharna BhattacharyyaAsoke G Datta
Feb 8, 2006·American Journal of Physiology. Renal Physiology·Kristin A Kirkby, Christopher A Adin
Oct 25, 2006·Journal of Leukocyte Biology·Vilma UrbonaviciuteReinhard E Voll
Jul 5, 2008·Arthritis Research & Therapy·David S PisetskyUlf Andersson
Nov 4, 2010·Molecular Medicine·Jochen Grommes, Oliver Soehnlein
Feb 16, 2011·Macromolecular Bioscience·Hamidreza Montazeri AliabadiHasan Uludağ
Apr 18, 2012·Macromolecular Bioscience·Remant Bahadur K CPeisheng Xu

❮ Previous
Next ❯

Citations

Mar 31, 2018·Frontiers in Microbiology·Zheng ZhangXiangna Zhao
May 13, 2019·ACS Biomaterials Science & Engineering·Chunxian PiaoMinhyung Lee
Sep 29, 2021·ACS Applied Materials & Interfaces·Myoungjee ChoiMinhyung Lee

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here